Gilead Sciences, Inc. (GILD)

68.85
0.75 1.10
NASDAQ
Prev Close 68.10
Open 68.69
Day Low/High 68.42 / 68.75
52 Wk Low/High 60.89 / 85.97
Volume 359.76K
Exchange NASDAQ
Shares Outstanding 1253.72B
Market Cap 85.89B
P/E Ratio 17.57
Div & Yield N.A. (N.A)
The Virus Remains in Control, Unrealistic V-Shaped Recovery, Trading 2 Stocks

The Virus Remains in Control, Unrealistic V-Shaped Recovery, Trading 2 Stocks

I do think the key to reopening this economy is one of greatly expanded testing for Covid-19, once a reliable treatment has made it past clinical testing, and into mass production.

Let's Cut Through All the Noisy Trading in Gilead Sciences

Let's Cut Through All the Noisy Trading in Gilead Sciences

Trading action has been jumpy, so where's the trend?

Market Review, Adapting to Change, Notes on 4 Stocks, Trading Gilead Sciences

Market Review, Adapting to Change, Notes on 4 Stocks, Trading Gilead Sciences

Over the past month, 3 sectors have revealed themselves as market leaders: Technology, Healthcare and Consumer Staples.

Some Optimism, Watching Oil, Trading Hain, Updating 4 Stocks: Market Recon

Some Optimism, Watching Oil, Trading Hain, Updating 4 Stocks: Market Recon

The presidential task force wasn't going to address the media Sunday. Then, they did. Actual news? Futures markets opened ahead of that, in the green, and went higher. That's interesting.

Real Money Post-Industrial Average Feels the Pain, But Continues to Outperform

Real Money Post-Industrial Average Feels the Pain, But Continues to Outperform

For March and the first quarter, the RMPIA takes less of a hit than major indexes.

Jim Cramer: Here Are the Quarter's Winners, Losers

Jim Cramer: Here Are the Quarter's Winners, Losers

The five best performing and worst performing stocks in the S&P 500 in the previous quarter pretty much tells the tale of the tape, so here goes.

Jim Cramer: Here's the Science Behind Our Rally

Jim Cramer: Here's the Science Behind Our Rally

While Johnson & Johnson and other pharma cos. give us hope, here's my wish list to keep the nation safe and the economy ready to go again.

In a Post-Coronavirus World, Put This Lesser-Known Stock on Your List

In a Post-Coronavirus World, Put This Lesser-Known Stock on Your List

Things will be different after Covid-19 and one change will be in how people care about themselves.

3 Japanese Stocks Getting a Boost on Potential Coronavirus Treatments

3 Japanese Stocks Getting a Boost on Potential Coronavirus Treatments

Japan is a leader in pharmaceuticals and has three companies working overtime to develop treatments for Covid-19.

A Look at Our Situation Now: Good, Bad, and Ugly, and 3 New Stock Groups

A Look at Our Situation Now: Good, Bad, and Ugly, and 3 New Stock Groups

Consider these stock model ideas: virus groups, work remotely, and fiscal.

Failed Rallies, Semiconductors Rising and the Fed's Big Guns

Failed Rallies, Semiconductors Rising and the Fed's Big Guns

The Fed has attacked developing problems in real-time -- and as China shows signs of life, the semi stocks are benefitting.

Licking Our Wounds and Waiting to See How the Covid-19 Story Plays Out

Licking Our Wounds and Waiting to See How the Covid-19 Story Plays Out

The next four to six weeks could determine whether the U.S. economy can recover from the coronavirus crisis without lasting damage

Mild Good News as Japanese Flu Drug Shows Promise in Mild Covid-19 Cases

Mild Good News as Japanese Flu Drug Shows Promise in Mild Covid-19 Cases

Fujifilm Holdings has a promising drug that seems to work in improving the outcome for coronavirus patients in China and Japan, though Avigan is a treatment not a cure.

Keeping Sane, the Profitable Way: How I'm Playing This Market

Keeping Sane, the Profitable Way: How I'm Playing This Market

I continue to shuttle new money into the market on declines using buy-write option strategies.

The Fed's Big Bazooka, Covid-19 Treatments, Market Breather

The Fed's Big Bazooka, Covid-19 Treatments, Market Breather

Amid dramatically rising jobless claims, the Fed continues to fire big bullets, the Senate is pushing its economic support package and Gilead and Regeneron have made progress on coronavirus treatments.

These Are the Times We Live In

These Are the Times We Live In

Here again is my approach and my three stock groups: 'rebound', 'revenue' and 'virus'.

Gilead Raised to Buy at DZ Bank

The Magic Mice of Regeneron

The Magic Mice of Regeneron

I am pretty well covered in my 'virus group'. I could definitely see bringing a few shares of REGN on board the next time the algorithms include that name in a broad selloff. Not before.

Volatility Yes, but There's Positive News Too

The market has gained some momentum. It looks like the administration might be readying to declare a national emergency. The president is scheduled to make comments starting an hour before the market close. I expect equities to continue to be volati...

5 Leading Biotechs in Search of a Coronavirus Vaccine

5 Leading Biotechs in Search of a Coronavirus Vaccine

The race is on. The prize could be countless lives saved and perhaps billions of dollars in revenue.

Early Rebound

Markets look like they will see a substantial rebound today, at least in the early going. S&P 500 futures are up some 5% just before the market opens. Gilead Sciences  just reported encouraging results around its experimental antiviral Remdesivir in...

Will Gilead Sciences Remdesivir Help Arrest the Coronavirus?

Will Gilead Sciences Remdesivir Help Arrest the Coronavirus?

Right now, GILD holds a strictly defensive spot among my holdings.

Coronavirus Impact Spreads, Market Selloff, Fed Action, Risk Tolerance

Coronavirus Impact Spreads, Market Selloff, Fed Action, Risk Tolerance

What came first? The chicken or the egg? The bear market or the pandemic? I don't care much for labels.

Don't Do the Coronavirus Chase

Don't Do the Coronavirus Chase

There are small vaccine and testing companies that see their shares spike when a new virus hits, but whether those gains will last is questionable.

The Oil Factor, 50 Year Bonds, Trading Clorox and Gilead Sciences: Market Recon

The Oil Factor, 50 Year Bonds, Trading Clorox and Gilead Sciences: Market Recon

The question begs... 'Do significantly lower oil prices provoke increased demand?' Anywhere?

Jim Cramer: Rate Cut No Cure for Coronavirus

Jim Cramer: Rate Cut No Cure for Coronavirus

But don't throw up your arms yet -- here are names that could be golden opportunities.

Roller Coaster Markets, Time for Emergency Measures, 3 Stock Groups to Focus On

Roller Coaster Markets, Time for Emergency Measures, 3 Stock Groups to Focus On

I'll stick to the three-pronged approach... the Rebound group, the Virus group, and the Revenue group.

Gilead Cut at DZ Bank

Market Outflows, Unknown Earnings Expectations and Trading Notes: Market Recon

Market Outflows, Unknown Earnings Expectations and Trading Notes: Market Recon

Here are a number of things that I'm watching now.

Playing the Hand You're Dealt

Playing the Hand You're Dealt

Check out just a few of the year-to-date moves coming into Thursday on 8 companies you've never heard of before the last week or two.